Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 August 2008, Vol. 112, No. 3, pp. 914-915.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuijpers, T. W.
Right arrow Articles by Roosnek, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kuijpers, T. W.
Right arrow Articles by Roosnek, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

CORRESPONDENCE

Human NK cells can control CMV infection in the absence of T cells

To the editor:

A 3-month-old girl, the first child of consanguineous parents with a family history of unexplained febrile episodes including a death from infection of the eldest brother of the father at 8 months of age, was admitted to our hospital for gastroenteritis. She had a mild leukocytosis (27.4 x 109/L) that was due mainly to an increased number of lymphocytes. After oral rehydration, the child recovered rapidly, and she was discharged after the fever had disappeared. We subsequently learned from the laboratory data that the clinical symptoms had been caused by cytomegalovirus (CMV). In addition, we found that the lymphocyte subsets causing the leukocytosis were extremely unbalanced; 90% were CD56dim natural killer (NK) cells, 10% were B cells, while T cells were virtually absent (0.07 x 109/L). Genetic analysis showed early stop codons in the patient's genes encoding the {alpha}-chain of the interleukin-7 (IL-7) receptor, a defect known to be associated with this particular TB+NK+ SCID-phenotype.1,2

The correlation between viral load, number of NK cells, and cytokine serum-levels during the follow up was very suggestive of a causal relation (Figure 1A-C). The extremely high number of NK cells (23.8 x 109/L) present at the peak of viremia (4.1 x 104 copies CMV-DNA/mL of serum) remained elevated for approximately 2 weeks. At that moment, NK cell–derived3 cytokines granulocyte macrophage–colony stimulating factor (GM-CSF) and interferon-{gamma} (IFN-{gamma}) and the ensuing IFN-{gamma} inducible protein-10 were at very high levels (Figure 1B,C). The viral load, already reduced by one log, decreased further to 150 copies/mL at 4 to 5 weeks and could not be detected anymore after the 6th week. By then, the number of NK cells had dropped to 2 x 109/L and the cytokines had returned to normal levels (Figure 1B,C, gray bars).


Figure 1
View larger version (28K):
[in this window]
[in a new window]

 
Figure 1. Kinetics of NK-cell expansion and cytokine serum-levels in relation to viral load, and phenotype of the expanded NK cells. (A) Number of CMV-DNA copies ({blacksquare}-{blacksquare}) and number of NK cells ({diamond}-{diamond}). The number of NK in the last sample (day 50) is at the upper limit of that in normal age-matched controls. -> indicates the first day of oral valganciclovir given to maintain CMV suppression. (B,C) Serum cytokine-levels during viremia (Figure 1, day 9 in panel A) and in a late CMV-DNA free sample (Figure 1, day 43 in panel A). {square} depicts the mean value plus or minus SD in 10 healthy controls. (D) FACS analysis of the respective marker with gates on CD3-CD56+ lymphocytes.

 
The phenotype of the NK cells expanded at the peak of infection had several interesting features (Figure 1D). Half the population expressed the low-affinity Fc{gamma}-receptor type 3 (CD16) only at low density, a phenomenon characteristic of activated CD56dim NK cells.4 All cells expressed CD94 of which most was dimerized with NKG2C. NK cells expressing activating CD94-NKG2C receptors, which are rare (< 1%) in CMV individuals,5 may be triggered directly by CMV-infected fibroblasts.6 Furthermore, the killer cell immunoglobulin-like receptors (KIR) repertoire appeared to be biased as more than 80% of NK cells were stained by a monoclonal antibody specific for KIR2DL2/2DS2/2DL3, while the other KIR, all present in the patient's genome, were expressed by less than 10% of NK cells (not shown).

To what extent NK cells contribute to human antiviral responses is unknown. Patients with diminished NK-cell functions may suffer from severe viral infections,710 but this may also be due to lack of guidance of the adaptive immune system by NK cell–derived cytokines. Here, we report a TB+NK+ SCID patient who recovered from CMV disease without antiviral therapy after a significant expansion of IFN-{gamma}–producing CD16+CD94-NKG2C+ NK cells had occurred. To our knowledge, this case provides the first direct evidence that human NK cells can effectively control CMV infection in the absence of T cells.

Authorship

We thank Dr J.-M. Tiercy for KIR genotyping and Mrs Solange Vischer for expert technical assistance.

E.R. is supported by a grant of the Swiss National Science Foundation (#3100-112612) and by the "Dr Henri Dubois-Ferrière-Dinu Lipatti" Foundation.

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Correspondence: Taco W. Kuijpers, MD, PhD, Emma Children's Hospital, Academic Medical Center (Room G8-205), Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; e-mail: t.w.kuijpers{at}amc.uva.nl.

Taco W. Kuijpers, Paul A. Baars, Carole Dantin, Mirjam van den Burg, Rene A. W. van Lier, and Eddy Roosnek

References

  1. Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet. 1998;20:394–397.[CrossRef][Medline] [Order article via Infotrieve]

  2. Roifman CM, Zhang J, Chitayat D, Sharfe N. A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency. Blood. 2000;96:2803–2807.[Abstract/Free Full Text]

  3. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol. 1999;17:189–220.[CrossRef][Medline] [Order article via Infotrieve]

  4. Loza MJ, Perussia B. The IL-12 signature: NK cell terminal CD56+high stage and effector functions. J Immunol. 2004;172:88–96.[Abstract/Free Full Text]

  5. Gumá M, Angulo A, Vilches C, Gomez-Lozano N, Malats N, Lopez-Botet M. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood. 2004;104:3664.[Abstract/Free Full Text]

  6. Gumá M, Budt M, Saez A, et al. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood. 2006;107:3624–3631.[Abstract/Free Full Text]

  7. Merino F, Henle W, Ramirez-Duque P. Chronic active Epstein-Barr virus infection in patients with Chediak-Higashi syndrome. J Clin Immunol. 1986;6:299–305.[CrossRef][Medline] [Order article via Infotrieve]

  8. Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med. 1989;320:1731–1735.[Medline] [Order article via Infotrieve]

  9. Joncas J, Monczak Y, Ghibu F, et al. Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection. J Med Virol. 1989;28:110–117.[Medline] [Order article via Infotrieve]

  10. Orange JS. Human natural killer cell deficiencies. Curr Opin Allergy Clin Immunol. 2006;6:399–409.[Medline] [Order article via Infotrieve]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
T. L. Geurs, Y. M. Zhao, E. B. Hill, and A. R. French
Ly49H Engagement Compensates for the Absence of Type I Interferon Signaling in Stimulating NK Cell Proliferation During Murine Cytomegalovirus Infection
J. Immunol., November 1, 2009; 183(9): 5830 - 5836.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuijpers, T. W.
Right arrow Articles by Roosnek, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kuijpers, T. W.
Right arrow Articles by Roosnek, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020